ABL1 interacts with factors like p53 to modulate cardiomyocyte responses to external insults, such as doxorubicin-induced mitochondrial toxicity and cardiomyopathy, involving pathways related to mitochondrial homeostasis, autophagy, apoptosis, and DNA damage response [98]. Here, ABL1 is linked to cardiomyopathy.